Results 51 to 60 of about 6,859 (188)
Fludrocortisone therapy for persistent hyperkalaemia
Background: Type 4 renal tubular acidosis causes hyperkalaemia, for which diabetes and medications commonly used in this patient group are aetiological factors. Here we describe the novel use of fludrocortisone in this difficult condition.
M. E. J. Lean +7 more
core +1 more source
Current Screening Strategies for the Diagnosis of Adrenal Insufficiency in Children
Sasigarn A Bowden Division of Endocrinology, Department of Pediatrics, Nationwide Children’s Hospital/The Ohio State University College of Medicine, Columbus, OH, USACorrespondence: Sasigarn A Bowden, Nationwide Children’s Hospital, Division of ...
Bowden SA
doaj
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
International audienceBackground - Septic shock is characterized by dysregulation of the host response to infection, with circulatory, cellular, and metabolic abnormalities.
Baudin, François +73 more
core +1 more source
Role of hydrocortisone with fludrocortisone early in septic shock: a randomized controlled study
Introduction Sepsis causes organ dysfunction due to the body’s response to infection, with early management essential. Septic shock involves persistent low blood pressure despite treatment, affecting all organ systems. Corticosteroids and glucocorticoids
Emad H. Hamouda +3 more
doaj +1 more source
We aimed to evaluate mineralocorticoid receptor (MR) expression in rat bladder and the physiological role of the MR-epithelial sodium channel (ENaC) pathway in controlling bladder function in 10–12-week-old, male Sprague–Dawley rats.
Seiji Yamamoto +9 more
doaj +1 more source
Background Management of sepsis is a time critical procedure; the consequences of improperly managed sepsis and septic shock can cause multiple organ dysfunction and death.
Heba A. Labib +4 more
doaj +1 more source
Abstract Background Postural orthostatic tachycardia syndrome (POTS) is a chronic form of orthostatic intolerance that primarily affects female patients. There are scarce data evaluating the long‐term outcomes in POTS. Objectives This study sought to evaluate the long‐term impacts of POTS over multiple decades in adult patients.
Kate M. Bourne +11 more
wiley +1 more source
CHARGE Syndrome: A Narrative Review and Update on Diagnosis, Assessment and Management
ABSTRACT Background CHARGE syndrome (CS) is a rare multisystemic genetic condition caused by a pathogenic variant in the DNA‐binding protein‐7 CHD7 gene. The condition affects the development of neural crest cells, which give rise to craniofacial structures, cranial nerves, ears, eyes and the heart, resulting in diverse and complex clinical features ...
Eleni M. van Gelder +7 more
wiley +1 more source
Ketoreductase from Pichia glucozyma (KRED1‐Pglu) has been successfully employed for the stereoselective bioreduction of α‐halogenated ketones using the purified protein, or alternatively a lyophilized whole cell preparation overexpressed in E. coli. Better chemoselectivities were found with pure biocatalyst, obtaining a series of chiral fluorohydrins ...
Marina García‐Ramos +4 more
wiley +1 more source
A Rare Clinical Presentation of Variegate Porphyria
WGS redirected the diagnostic focus, underscoring the complex interplay between porphyria and a potential MYMK‐related neuromuscular phenotype. ABSTRACT Background Variegate porphyria is a rare heme biosynthesis disorder caused by pathogenic variants in the PPOX gene.
I. Viakhireva +5 more
wiley +1 more source

